BHIC BioScience Health Innovations, Inc.

CIK 0001784440 5 ready 8-Ks latest April 2, 2026, 7:59 PM ET RSS · JSON

Activity: NORMAL 0 filings / 30d vs 0 baseline

Ready 8-Ks 5

Latest filing April 2, 2026, 7:59 PM ET

Top materiality 0.80

Event mix other_material ×3 · leadership ×1 · m_and_a ×1

Sentiment 0 pos · 1 neg · 4 neu

Executive change recent →

SHENANIGAN SCORE 2 / 7 see the board

Recent 8-K filings for BHIC

Highest-materiality recent filing

Nowtransit completes reverse merger with Best Labs; issues 34M shares (85.4%) for supplement business

June 25, 2024, 7:59 PM ET M&A materiality 0.80 neutral item 1.01 item 2.01 item 5.03 item 9.01 item 4.01 item 3.02 item 5.02 item 5.06 ◈ executive_change ×4◈ M&A Transactions

Issued 34,371,100 shares (85.39% of post-closing shares) to Best Labs shareholders for all of Best's shares; deal closed March 10, 2023.
Company exited online delivery business; now markets Be On-Guard mouth spray, nasal spray, surface cleaner, brain support supplements, and methylene blue products.

Read filing →

April 2, 2026, 7:59 PM ET leadership materiality 0.30 neutral item 5.02

Bioscience Health Innovations board member Justin Earl resigns; Daniel Schmidt appointed director

Justin Earl resigned from the board effective April 1, 2026, with no disagreement on company matters.
October 16, 2025, 7:59 PM ET other material materiality 0.50 neutral item 5.03 item 5.07 item 9.01 ◈ Governance Changes

BioScience Health Innovations enacts 4-for-1 reverse stock split effective Sept. 10, 2025

Reverse stock split ratio of 4 old shares to 1 new share, approved by board and majority stockholder written consent.
March 17, 2025, 7:59 PM ET other material materiality 0.30 neutral item 5.03

Nowtransit changes name to BioScience Health Innovations, Inc. effective Feb 21, 2025

Company name changed from Nowtransit, Inc. to BioScience Health Innovations, Inc. effective February 21, 2025.
June 25, 2024, 7:59 PM ET M&A materiality 0.80 neutral item 1.01 item 2.01 item 5.03 item 9.01 item 4.01 item 3.02 item 5.02 item 5.06 ◈ executive_change ×4◈ M&A Transactions

Nowtransit completes reverse merger with Best Labs; issues 34M shares (85.4%) for supplement business

Issued 34,371,100 shares (85.39% of post-closing shares) to Best Labs shareholders for all of Best's shares; deal closed March 10, 2023.
May 22, 2024, 7:59 PM ET other material materiality 0.50 negative item 4.01 item 9.01

Nowtransit dismisses Spiegel, appoints Mac as auditor after FY2022 going concern

Spiegel dismissed as auditor effective March 10, 2023; Mac appointed March 15, 2023.

Executive changes

Appointed

Darren Lopez

Director

BHIC · BioScience Health Innovations, Inc.

Filed: June 25, 2024, 7:59 PM ET

Darren Lopez and John Chymboryk were appointed to serve on the Board of Directors with Justin Earl.

Departed

Justin Earl

Chief Executive Officer

BHIC · BioScience Health Innovations, Inc.

Successor: Darren Lopez
Filed: June 25, 2024, 7:59 PM ET

Justin Earl tendered his resignation as the sole officer of the Company.

Appointed

John Chymboryk

Director

BHIC · BioScience Health Innovations, Inc.

Filed: June 25, 2024, 7:59 PM ET

Darren Lopez and John Chymboryk were appointed to serve on the Board of Directors with Justin Earl.

Appointed

Darren Lopez

Chief Executive Officer

BHIC · BioScience Health Innovations, Inc.

Filed: June 25, 2024, 7:59 PM ET

Darren López was appointed as the Chief Executive Officer of the Company.

Materiality & sentiment trend

Max materiality 0.80 · Median 0.50 · Most common event other_material

0 positive 1 negative 4 neutral

source · BHIC on sec.gov